RC

Ravi Chetan Belani

Active Director Director DIN 01868128
DIN 01868128 First appointment Jun 1994 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 1994
Shareholding value •••• Premium profile

About Ravi Chetan Belani

Data last updated:

Ravi Chetan Belani is a Director at Enoch Pharmaceuticals Private Limited (since 1994). The company operates in Chemicals. Enoch Pharmaceuticals Private Limited reported revenue of ₹1.7 Lakh (FY 2020).

DIN 01868128
Primary Designation Director
Industry Chemicals
First Appointment 15 Jun 1994
Oldest Company Age 32 yrs
Largest company Enoch Pharmaceuticals Private Limited · ₹1.7 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Jun 19941994₹1.7 Lakh (FY 2020)Active

Board colleagues of Ravi Chetan Belani

Directorship timeline

Open interactive timeline →
Enoch Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ravi Chetan Belani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Chetan Belani

Ravi Chetan Belani currently holds 1 directorship: Enoch Pharmaceuticals Private Limited (Director, since 15 Jun 1994, revenue ₹1.7 Lakh (FY 2020)).

Ravi Chetan Belani was first appointed on 15 Jun 1994 as Director at Enoch Pharmaceuticals Private Limited.

The current boards of Ravi Chetan Belani's companies include Deepika Ravi Belani (Enoch Pharmaceuticals Private Limited), Seema Ravi Belani (Enoch Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available